Tetsuyuki (Tetsu) Maruyama, PhD, Executive Director

As Executive Director of ADDI, Tetsu has the pleasure of working with an exceptional team to enable data relevant to Alzheimer’s and related dementias to reach their full potential.

Prior to joining ADDI, Tetsu was the Chief Scientific Officer at the Dementia Discovery Fund, a unique venture capital fund focusing a total investment of $350 million on creating new treatment paradigms for dementia. Before that he was head of Drug Discovery for Takeda Pharmaceuticals in Japan, and led the GSK Centre for Cognitive and Neurodegenerative Disorders in Singapore. He began his industry career at Merck Sharp and Dohme’s Neuroscience Research Center in the UK, after 15 years as an academic neuroscientist at Cardiff University and the University of Minnesota.

Tetsu has contributed to the promotion of open science, having been Chairperson of the Board of the Structural Genomics Consortium from 2016 through 2020, and a member of the Board of Directors of Sage Bionetworks. He is currently on the Board of Directors or Scientific Advisory Board of a number of privately held biotech companies and is a member of the World Dementia Council.

Tetsu earned his PhD in Behavioral Neuroscience from Stanford University and completed post-doctoral research in Neurophysiology at Yale University. If you catch Tetsu on a videoconference, don’t let the guitars in the background fool you. This former front man for the band Pretty Risky Decision is clear: his enthusiasm greatly exceeds his talent.

Patrick Brannelly, Director of Partnerships & Business Development

As Director of Partnerships & Business Development for ADDI, Pat oversees strategic planning efforts, cultivates new partnerships, and guides complex negotiations on behalf of the organization.

Prior to ADDI, Pat spent seven years at the Rainwater Charitable Foundation where he was the Managing Director of the Tau Consortium. The mission of the Tau Consortium is to accelerate the development of new treatments for Alzheimer’s disease, frontotemporal dementia, and related disorders through increased collaboration among academia, industry, and the philanthropic sector.

In the decade prior to joining the Tau Consortium, Pat was the co-founder and CEO of NeoCORTA and the Director of Partnerships & Group Programs at Posit Science, both early stage brain health technology ventures. Earlier in his career, he served in the US and Europe as a management consultant in the pharmaceutical, energy, and technology sectors. He is a former Assistant Professor of entrepreneurship and strategy at California State University, Fresno. A frequent member of boards and steering committees within the neuroscience community, he currently serves as a founding Board member of Stroke Onward.

Pat holds a Bachelor of Arts in Psychology from Harvard College and an MBA with Distinction from Harvard Business School. As the father of two young kids, he spends his free time building forts, watching animated films, and running a non-profit taxi service.

Maren Claassen, Senior Executive Business Administrator

As Senior Executive Business Administrator for ADDI, Maren is involved in the management of daily operations, contributing to the strategic direction of the organization, and working closely with ADDI’s Executive Leadership team.

Prior to ADDI she spent 10 years at the Bill & Melinda Gates Foundation where she implemented and led the CEO’s internal and external engagements to further their mission of helping all people lead healthy, productive lives. Maren brings 15 years of experience in administrative and strategic operations in both non-profit and for-profit organizations, including several years in the tech industry in the San Francisco Bay area.

Maren holds a Bachelor of Arts in Philosophy from Azusa Pacific University. She currently resides outside of Seattle on an urban farm with her husband, daughter, and two loyal dogs.

Matthew Clement, PhD, Director of Partnerships & Scientific Strategy

As Director of Partnerships & Scientific Strategy for ADDI, Matt develops relationships with new partners and data providers to enable researchers to accelerate progress toward new treatments through use of the AD Workbench (ADWB).

Prior to helping lay the groundwork for ADDI’s launch in 2020, Matt worked as a consultant for organizations funding R&D activities in the philanthropic and federal government sectors. His areas of expertise include program management, strategic planning, source selection and proposal evaluation, and scientific writing and subject matter expertise. Matt’s past work has focused on microbial metabolism and genetics, biomarker discovery, assay and diagnostic development, neurodegenerative disease, and biological threat agent surveillance and detection.

Matt earned his PhD in Biochemistry and Molecular Biology from UCLA and his Bachelor of Arts in Chemistry from Macalester College. When away from the office, Matt enjoys cycling, golfing, skiing, and spending time with his family.

Caitlin McHugh, PhD, Bioinformatics Scientist

As Bioinformatics Scientist for ADDI, Caitlin develops and incorporates bioinformatics tools into the AD Workbench (ADWB), manages data science technical workstreams, and works with the technical team to incorporate the needs of the scientific community.

An accomplished statistical geneticist, Caitlin’s area of expertise includes developing statistical models and applying them to large-scale human genetics data with phenotypes of interest ranging from BMI and ECG measurements to Huntington’s Disease and primary open angle glaucoma. Prior to joining the ADDI team, she worked as a research scientist at the University of Washington where she was a core member of the data coordinating center for TOPMed, a consortium generating whole genome sequence data for 150,000 participants across more than 80 studies. Caitlin also worked with the Cardiovascular Health Study (CHS), a cohort study started in 1989 by the University of Washington. Her projects included making computationally efficient the estimation of pairwise relatedness using more than 1 million genetic markers and 100,000+ participants, and coordinating all non-genetics omics data for 50+ projects.

Caitlin earned her PhD in Biostatistics from the University of Washington, a Master of Science in Applicable Mathematics from the London School of Economics, and a Bachelor of Science in Mathematics from Seattle University. When she’s not chasing after her 2-year-old daughter, she loves to knit.

Mukta Phatak, PhD, Director of Data Science

As Director of Data Science for ADDI, Mukta is responsible for creating a technical roadmap for the AD Workbench (ADWB) and strategy for data science features and functionality, which also includes engaging with the AD data science community to understand user experiences and identifying and converting gaps into business requirements for the Workbench.

Prior to joining ADDI, Mukta was Director, Data and Analytics with the Chief Data Office organization at GE Aviation. Her responsibilities included leading development of a cloud-based ecosystem to enable unified data strategy for aviation value streams and scaling products from self-service proof of concepts to enterprise-level products.

Mukta earned her PhD in Biomedical Engineering from the University of Cincinnati with a focus on bioinformatics, and a Bachelor of Science in Computer Science in Pune, India. Her areas of work include predictive modeling, next-gen sequencing data analysis, development of data portals for integrative analysis of genomics and proteomics data, and enterprise class cloud-based data analytics solutions. She lives in Seattle with her spouse and child where she likes to paint, sing, and practice yoga when she’s not travelling internationally.

Kelly Sparks, Senior IT Architect

As Senior IT Architect for ADDI, Kelly is responsible for overall strategic direction, product roadmaps and partner integration strategies. He also drives several application development efforts including tools for harmonization, federated data access, and operations management.

Kelly is a veteran technology executive with over 30 years of diverse information technology executive-level leadership. His experience in large enterprises, mid-tier companies and startups enables him to bring fresh, innovative ideas and strategic thinking into every opportunity and engagement. Prior to ADDI, Kelly held many roles including CEO, CTO, President, Product Marketing and Product Development in small and large firms including 11 years as a decorated sales leader at IBM. He has developed and authored over 25 patents and patent applications in identity management and digital media, and is currently managing partner at aPersona, Inc., a pioneer in identity management technology.

Kelly holds a Bachelor of Science in Computer Information Systems from Southern Polytechnic State University. He currently resides in Raleigh, NC with his spouse, Becky, and their two labradoodles, Panda and Paddington.

Tom Swanson, Program Management Office Lead

As the lead of ADDI’s Program Management Office, Tom is responsible for introducing and maintaining a consistent approach to the execution and management of the organization’s programs and operations. Throughout his career, Tom has focused on establishing efficient project management methodologies to support successful product and program development and strengthen the integration of partner alliances and program teams.

Prior to ADDI, Tom spent more than two decades in the biopharmaceutical sector involved in strategy development and program operations. As Senior Director of Strategy and Operations at Zinfandel Pharmaceuticals, Tom oversaw management of the company’s Phase 3 Alzheimer’s disease combination genetic bio-marker prognostic and drug development program alliance with Takeda Pharmaceuticals. He led strategy development and operational integration for the adoption of genetics as part of drug development and improved R&D pipeline management in his role as Director, Pharmacogenetics Program & Project Management at Cabernet Pharmaceuticals. At First Genetic Trust, Tom managed the development of software to enhance genetic research collaboration. He has also served in program management and operational roles supporting research and development at GSK and Eli Lilly.

Tom holds a Bachelor of Science in Engineering from the University of Wisconsin and an MBA from the University of Houston. In his spare time Tom coaches youth baseball and football.